Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

152
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
152
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

170
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
170
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

168
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
168
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

126
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
126
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

181
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
181
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

804
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
804

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same journal

ANALYSIS OF SHORT-CHAIN FATTY ACIDS AND ASSOCIATION WITH GLUCAGON-LIKE PEPTIDE-1 IN HEALTHY, OBESE, PREDIABETES AND TYPE 2 DIABETES INDIVIDUALS.

Acta endocrinologica (Bucharest, Romania : 2005)·2026
Same journal

ASSESSMENT OF NON-ENDOCRINOLOGIST PHYSICIANS' AWARENESS OF DIABETES TECHNOLOGIES: A NATIONWIDE SURVEY IN TURKEY.

Acta endocrinologica (Bucharest, Romania : 2005)·2026
Same journal

EARLY REASSURANCE OR FALSE SAFETY? THE FETAL HOME DOPPLER USE IN ACTIVE MONITORING IN THE FIRST TRIMESTER OF PREGNANCY - FROM THE ENDOCRINE PERSPECTIVE.

Acta endocrinologica (Bucharest, Romania : 2005)·2026
Same journal

LEVOTHYROXINE-SIMETHICONE DRUG INTERACTION AND PRESENCE OF MACRO-TSH IN AN INFANT WITH CONGENITAL HYPOTHYROIDISM.

Acta endocrinologica (Bucharest, Romania : 2005)·2026
Same journal

DIAGNOSIS OF ACROMEGALY IN BILATERAL CARPAL TUNNEL SYNDROME AND FOLLOW-UP WITH ULTRASONOGRAPHY: A CASE REPORT.

Acta endocrinologica (Bucharest, Romania : 2005)·2026
Same journal

DIFFERENTIAL METABOLIC AND INFLAMMATORY RESPONSES TO ACUTE HYPERGLYCAEMIA IN ISCHAEMIC STROKE: IMPLICATIONS FOR DIABETES STRATIFICATION AND EARLY PROGNOSTICATION.

Acta endocrinologica (Bucharest, Romania : 2005)·2026
See all related articles

Related Experiment Video

Updated: Dec 6, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.9K

CUSHING'S SYNDROME, A RISK FACTOR FOR VENOUS THROMBOEMBOLISM IS A CANDIDATE FOR GUIDELINES.

G Koraćević1,2, M Stojanović3, S Petrović4,2

  • 1Clinical Centre Niš - Department for Cardiovascular Diseases, Novi Sad Serbia.

Acta Endocrinologica (Bucharest, Romania : 2005)
|October 8, 2020
PubMed
Summary
This summary is machine-generated.

Patients with Cushing's syndrome (CS) face a significantly higher risk of venous thromboembolism (VTE), with endogenous CS patients showing an 18-fold increased risk. This elevated VTE risk, particularly in the first year post-diagnosis, is often overlooked in clinical guidelines.

Keywords:
Cushing’s syndromedeep vein thrombosisguidelinespulmonary embolismvenous thromboembolism

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

15.3K
Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

4.8K

Related Experiment Videos

Last Updated: Dec 6, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.9K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

15.3K
Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
08:05

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

4.8K

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Oncology

Background:

  • Cushing's syndrome (CS) is associated with significant morbidity, but its link to venous thromboembolism (VTE) remains under-recognized.
  • A discrepancy exists between meta-analyses confirming increased VTE risk in CS and its absence in current VTE guidelines.

Purpose of the Study:

  • To review contemporary information on VTE risk in endogenous and exogenous CS.
  • To highlight the discrepancy between established VTE risk in CS and its omission from clinical guidelines.

Main Methods:

  • Extensive literature search of PubMed, Google Scholar, and Scopus.
  • Keywords included Cushing's syndrome, venous thromboembolism, deep vein thrombosis, and pulmonary embolism.

Main Results:

  • Patients with CS exhibit approximately a tenfold increased risk for VTE, especially within the first year of diagnosis.
  • Oral glucocorticoid use (iatrogenic CS) confers a threefold VTE risk increase.
  • A 2019 meta-analysis revealed an 18-fold higher risk of unprovoked VTE in patients with endogenous CS compared to the general population.

Conclusions:

  • Substantial evidence accumulated over 50 years confirms elevated VTE risk in both endogenous and exogenous CS.
  • Official guidelines fail to acknowledge CS as a VTE risk factor, necessitating increased physician awareness.
  • Physicians treating CS and VTE should be cognizant of this significant risk.